The present invention relates generally to artificial seeds and, more particularly, to multi-embryo manufactured seeds.
Asexual propagation of plants has been shown for some species to yield large numbers of genetically identical embryos, each having a capacity to develop into a normal plant. Such embryos are usually further cultured under laboratory conditions until they reach an autotrophic “seedling” state characterized by an ability to produce its own food via photosynthesis, resist desiccation, produce roots able to penetrate soil, and fend off soil microorganisms. Some researchers have experimented with the production of artificial seeds, known as manufactured seeds, in which individual plant somatic or zygotic embryos are encapsulated in a seed coat. Examples of such manufactured seeds are disclosed in U.S. Pat. No. 5,701,699, issued to Carlson et al., the disclosure of which is hereby expressly incorporated by reference.
Typical manufactured seeds include a seed shell, synthetic gametophyte and a plant embryo. A manufactured seed that does not include the plant embryo is known in the art as a “seed blank.” The seed blank typically is a cylindrical capsule having a closed end and an open end. The synthetic gametophyte is placed within the seed shell to substantially fill the interior of the seed shell. A longitudinally extending hard porous insert, known as a cotyledon restraint, may be centrally located within one end of the seed shell, surrounded by the synthetic gametophyte, and includes a centrally located cavity extending partially through the length of the cotyledon restraint.
The cavity is sized to receive the plant embryo therein. The well-known plant embryo includes a radicle end and a cotyledon end. The plant embryo is deposited within the cavity of the cotyledon restraint, cotyledon end first. The plant embryo is then sealed within the seed blank by at least one end seal. There is a weakened spot in the end seal to allow the radicle end of the plant embryo to penetrate the end seal.
After a relatively large number of manufactured seeds are assembled, they are sowed in a nursery bed. As such, they are allowed to germinate with the anticipation of yielding a large number of healthy seedlings having desired characteristics. Although currently available manufactured seeds are relatively successful in yielding a reasonable number of healthy seedlings, such manufactured seeds are not without problems.
As an example, research has shown that embryo quality can reduce the germination of manufactured seeds. As a non-limiting example, with one set of embryos, germination was 50%. This can be improved by various sorting methods. As a result, as measured against the successful yield rate, the cost of manufactured seeds with low quality embryos is proportionately higher when evaluated against crop yield.
Thus, there exists a need for a multi-embryo manufactured seed that produces a higher successful yield rate than those currently available in the art.
A manufactured seed is provided. The manufactured seed includes a first seed shell and a first restraint disposed within the first seed shell. The manufactured seed also includes at least two embryos disposed within the manufactured seed. In another embodiment of the present invention, the manufactured seed also includes a second seed shell coupled to the first seed shell, and includes a second restraint having a cavity. In this embodiment, one of the at least two embryos is disposed within the cavity of the first restraint and another of the least two embryos is disposed within the cavity of the second restraint.
In yet another embodiment of the present invention, the first and second seed shells are coaxially aligned. In still yet another embodiment, the manufactured seed includes a plurality of restraints disposed in one end of the first seed shell.
A multi-embryo manufactured seed formed in accordance with various embodiments of the present invention has several advantages over currently available manufactured seeds. Because the multi-embryo manufactured seed of the present invention includes at least two embryos, there is a greater chance of producing a manufactured seed yielding an acceptable successful seedling rate per manufactured seed. Further, because multiple embryos are disposed in each manufactured seed, the need to evaluate and segregate qualified embryos from unqualified embryos prior to insertion into the manufactured seed is reduced. This results in a more cost effective manufactured seed as a time consuming step in the manufactured seed assembly is eliminated.
Thus, a multi-embryo manufactured seed formed in accordance with the various embodiments of the present invention has a high degree of reliability, and is capable of mass production at a relatively low cost.
The foregoing aspects and many of the attendant advantages of this invention will become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
The first seed 22a includes a seed shell 30a, a cotyledon restraint 32a, and an embryo 34a. The interior of the seed shell 30a is filled with a nutritive media 36a. Such a seed 22a is disclosed in U.S. Pat. No. 5,701,699, issued to Carlson et al., the disclosure of which is hereby expressly incorporated by reference.
The seed shell 30a is suitably formed from a tubular material, such as a straw of fibrous material, and is sectioned in appropriate lengths. The cotyledon restraint 32a is suitably manufactured from a hard, porous material, such as ceramic, and includes a longitudinally extending cavity 38a. The cavity 38a extends partially through one end of the cotyledon restraint 32b and includes an open end known as a cotyledon restraint opening 40a. The cavity 38a is sized to receive the plant embryo 34a therein.
Still referring to
As assembled, the manufactured seed 20 is then distributed in a nursery bed where the embryos 34a and 34b are permitted to germinate. In some circumstances, both embryos 34a and 34b are healthy embryos and each germinates to yield an acceptable seedling. However, in other circumstances, only one of the two embryos 34a and 34b successfully germinate to produce a desirable seedling.
Referring now to
Referring now to
A manufactured seed 320 formed in accordance with another embodiment of the present invention may be best understood by referring to
Referring next to
A manufactured seed 520 formed in accordance with still yet another embodiment of the present invention may be best understood by referring to
Although the present embodiment is described as containing only four cotyledon restraints, it should be apparent that other embodiments are also within the scope of the present invention. As an example, such a manufactured seed may include two, three, five, or any other combination of cotyledon restraints within the one end of the seed shell 22a. As another example, multiple cotyledon restraints may be disposed in both ends of the seed shell 22a, such that a plurality of embryos are disposed in both ends of the seed shell 22a. Accordingly, such embodiments are also within the scope of the present invention.
As may be best seen by referring to
It should be apparent that although a cotyledon restraint 632 with a total of four cavities 638a-638d, is illustrated and described, other cotyledon restraints, such as a cotyledon restraint with two, three, five, six, or more cavities, are also within the scope of the present invention. It should also be apparent that the manufactured seed may include two identically configured, single restraints having a plurality of cavities inserted into both ends of the seed coat. As yet another embodiment, a manufactured seed having, in one end, a single restraint with a plurality of cavities, and a plurality of restraints disposed in the other end of the seed coat. Accordingly, such embodiments are also within the scope of the present invention.
While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.
The present application claims the benefit of U.S. Provisional Application No. 60/529,133, filed Dec. 12, 2003.
Number | Name | Date | Kind |
---|---|---|---|
2309702 | Kirschenbaum | Feb 1943 | A |
2502809 | Vogelsang | Apr 1950 | A |
2809772 | Weisz | Oct 1957 | A |
3034905 | Weintraub et al. | May 1962 | A |
3098320 | Estkowski et al. | Jul 1963 | A |
3545129 | Schreiber et al. | Dec 1970 | A |
3688437 | Hamrin | Sep 1972 | A |
3690034 | Knapp | Sep 1972 | A |
3734987 | Hamrin | May 1973 | A |
3850753 | Chibata et al. | Nov 1974 | A |
4147930 | Browne et al. | Apr 1979 | A |
4166006 | Hertl et al. | Aug 1979 | A |
4252827 | Yokoyama et al. | Feb 1981 | A |
4465017 | Simmons | Aug 1984 | A |
4562663 | Redenbaugh | Jan 1986 | A |
4583320 | Redenbaugh | Apr 1986 | A |
4615141 | Janick et al. | Oct 1986 | A |
4628633 | Nilsson | Dec 1986 | A |
4665648 | Branco et al. | May 1987 | A |
4715143 | Redenbaugh et al. | Dec 1987 | A |
4769945 | Motoyama et al. | Sep 1988 | A |
4777762 | Redenbaugh et al. | Oct 1988 | A |
4777907 | Sänger | Oct 1988 | A |
4779376 | Redenbaugh | Oct 1988 | A |
4780987 | Nelsen et al. | Nov 1988 | A |
4802305 | Kojimoto et al. | Feb 1989 | A |
4802905 | Spector | Feb 1989 | A |
4806357 | Garrett et al. | Feb 1989 | A |
4808430 | Kouno | Feb 1989 | A |
4866096 | Schweighardt | Sep 1989 | A |
4879839 | Gago et al. | Nov 1989 | A |
5010685 | Sakamoto et al. | Apr 1991 | A |
5044116 | Gago et al. | Sep 1991 | A |
5181259 | Rorvig | Jan 1993 | A |
5183757 | Roberts | Feb 1993 | A |
5236469 | Carlson et al. | Aug 1993 | A |
5250082 | Teng et al. | Oct 1993 | A |
5258132 | Kamel et al. | Nov 1993 | A |
5284765 | Bryan et al. | Feb 1994 | A |
5427593 | Carlson et al. | Jun 1995 | A |
5451241 | Cartson et al. | Sep 1995 | A |
5464769 | Attree et al. | Nov 1995 | A |
5529597 | Iijima | Jun 1996 | A |
5564224 | Carlson et al. | Oct 1996 | A |
5565355 | Smith | Oct 1996 | A |
5666762 | Carlson et al. | Sep 1997 | A |
5680320 | Helmer et al. | Oct 1997 | A |
5687504 | Carlson et al. | Nov 1997 | A |
5701699 | Carlson et al. | Dec 1997 | A |
5732505 | Carlson et al. | Mar 1998 | A |
5771632 | Liu et al. | Jun 1998 | A |
5784162 | Carib et al. | Jul 1998 | A |
5799439 | MacGregor | Sep 1998 | A |
5821126 | Durzan et al. | Oct 1998 | A |
5842150 | Renberg et al. | Nov 1998 | A |
5877850 | Ogata | Mar 1999 | A |
5930803 | Becker et al. | Jul 1999 | A |
5960435 | Rathmann et al. | Sep 1999 | A |
6021220 | Anderholm | Feb 2000 | A |
6092059 | Straforini et al. | Jul 2000 | A |
6119395 | Hartle et al. | Sep 2000 | A |
6145247 | McKinnis | Nov 2000 | A |
6470623 | Hirahara | Oct 2002 | B1 |
6567538 | Pelletier | May 2003 | B1 |
6582159 | McKinnis | Jun 2003 | B2 |
20020192686 | Adorjan et al. | Dec 2002 | A1 |
20030055615 | Zhang et al. | Mar 2003 | A1 |
Number | Date | Country |
---|---|---|
1241552 | Sep 1988 | CA |
1250296 | Feb 1989 | CA |
0 107 141 | May 1984 | EP |
0 300 730 | Jan 1989 | EP |
0 380 692 | Aug 1990 | EP |
0776601 | Jun 1997 | EP |
2 680 951 | Mar 1993 | FR |
61040708 | Feb 1986 | JP |
62275604 | Nov 1987 | JP |
63133904 | Jun 1988 | JP |
63152905 | Jun 1988 | JP |
2-46240 | Feb 1990 | JP |
407179683 | Jul 1995 | JP |
WO 9100781 | Jan 1991 | WO |
WO 9101803 | Feb 1991 | WO |
WO 9207457 | May 1992 | WO |
WO 9505064 | Feb 1995 | WO |
WO 9833375 | Aug 1998 | WO |
WO 9926470 | Jun 1999 | WO |
Number | Date | Country | |
---|---|---|---|
20050132436 A1 | Jun 2005 | US |
Number | Date | Country | |
---|---|---|---|
60529133 | Dec 2003 | US |